Rep. Cleo Fields (D-LA) Buys Quantinuum (QNT) Stock
Democratic Representative Cleo Fields disclosed buying QNT shares in June.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Cleo Fields (D-LA) bought between $1,001 and $15,000 of Quantinuum Inc. ($QNT) stock on June 4, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed June 26, 2026.
Since the trade, $QNT is down 6.4% after 1 week, up 37.7% after 1 month and down 39.5% to date (from the $60.38 close on Jun 4, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Cleo Fields (D-LA)
- Status:
- Member — House
- State/District:
- LA-6
- Party:
- democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 26, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Quantinuum Inc. ($QNT) | Buy | Jun 4, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
Key Points
- Democratic Rep. Cleo Fields bought QNT shares valued between $1,001 and $15,000 on June 4, 2026.
- QNT traded at $75.57 on Monday, with insiders like CFO Nitesh Sharan buying shares at $60 each.
- Analysts from firms like Jefferies and Rosenblatt initiated QNT coverage with 'buy' ratings and targets up to $155.
Get $QNT trade alerts by text
We text you when insiders, Congress or big funds trade $QNT. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Quantinuum Inc. alert may contain errors. Disclosures
Democratic Representative Cleo Fields from Louisiana's 6th district recently disclosed buying shares of QNT, valued between $1,001 and $15,000. This transaction took place on June 4, 2026, and was reported later in the month. Fields is a member of the House and represents the Democratic party.
Cleo Fields vs. the S&P 500
Hypothetical returns from Cleo Fields's disclosed trades, not real profit or advice. How we model this.
Insider Buying and Selling at Quantinuum Inc.
Several insiders at QNT made notable purchases on June 5, 2026. Michal Stepniak acquired 13,333 shares, while Joseph Jimenez bought 66,665 shares. Vimal Kapur added 13,000 shares to his holdings. Eric Branderiz purchased 8,334 shares, and Prineha Narang acquired 200 shares. Notably, Nitesh Sharan, the Chief Financial Officer, bought 6,500 shares. All these transactions were made at an average price of $60 per share and were not part of a pre-planned trading scheme.
Analysts Set New Price Targets
On June 29, 2026, several analysts initiated coverage on QNT with positive outlooks. Jefferies and Cantor Fitzgerald both started with 'buy' ratings and set a price target of $90. Craig-Hallum and B of A Securities also recommended 'buy', with targets of $100. Meanwhile, Rosenblatt was more optimistic, setting a target of $155. Mizuho and Evercore ISI Group joined in with 'buy' ratings and targets of $90 and $98, respectively. Needham also supported the stock with a $100 target.
Bottom Line
Cleo Fields' purchase of QNT shares, alongside significant insider buying, suggests confidence in the company's prospects. The stock's current trading price and the range of analyst price targets indicate varying levels of optimism about its future performance. While 13F filings and insider transactions provide valuable insights, they are historical and may not reflect the latest positions or market conditions.
Source: Cleo Fields's STOCK Act disclosure on $QNT (Jun 4, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts